DISCO study
The DISCO study investigates whether attempting to stop methotrexate or leflunomide is possible for rheumatoid arthritis patients using a TNF inhibitor with low disease activity.

Rheumatoid arthritis causes pain, stiffness, and joint damage. Patients often use a combination of methotrexate or leflunomide and a TNF inhibitor. This is effective, but often causes side effects, and using multiple medications is burdensome. We are investigating whether patients with low disease activity can safely attempt to stop their methotrexate or leflunomide. In this study, 202 participants are randomly assigned: one group stops methotrexate or leflunomide, while the other group continues the combination treatment. Participation lasts 2 years, during which we closely monitor disease activity.
Project information
Project lead: Nathan den Broeder
Contact person: Sophie Gerritsen
Project team: Alfons den Broeder and Pauline Groenen

